Clinical trials
Acute Kidney Injury trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 9 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 8 |
| 2019 | 1 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 10 |
| Unknown status | 10 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guy's and St Thomas' NHS Foundation Trust | 9 |
| University Hospitals of Derby and Burton NHS Foundation Trust | 5 |
| The Royal Wolverhampton Hospitals NHS Trust | 4 |
| University of Edinburgh | 4 |
| King's College Hospital NHS Trust | 3 |
| University Hospital Muenster | 3 |
| University of Leicester | 3 |
| AstraZeneca | 2 |
| Astute Medical, Inc. | 2 |
| Barts & The London NHS Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Kidney Injury | 71 |
| Renal Insufficiency, Chronic | 8 |
| Critical Illness | 5 |
| Kidney Diseases | 4 |
| Sepsis | 4 |
| COVID-19 | 2 |
| Coronary Artery Disease | 2 |
| Renal Insufficiency | 2 |
| Shock, Septic | 2 |
| Acute Chest Syndrome | 1 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.